Cargando…
Outcome of Non-Muscle Invasive Upper Tract Urothelial Carcinoma Receiving Endoscopic Ablation: An Inverse Probability of Treatment Weighting Analysis
We compared the outcomes in early-stage upper tract urothelial carcinoma (UTUC) patients receiving endoscopic ablation (EA) with radical nephroureterectomy (RNU). From 2004 to 2018, cTa/T1N0M0 UTUC patients undergoing EA and RNU were enrolled. For reducing observational bias, propensity scores based...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910842/ https://www.ncbi.nlm.nih.gov/pubmed/35268398 http://dx.doi.org/10.3390/jcm11051307 |
_version_ | 1784666593573208064 |
---|---|
author | Shen, Chih-Yu Jou, Yeong-Chin Kan, Wei-Chih Tzai, Tzong-Shin Tsai, Yuh-Shyan |
author_facet | Shen, Chih-Yu Jou, Yeong-Chin Kan, Wei-Chih Tzai, Tzong-Shin Tsai, Yuh-Shyan |
author_sort | Shen, Chih-Yu |
collection | PubMed |
description | We compared the outcomes in early-stage upper tract urothelial carcinoma (UTUC) patients receiving endoscopic ablation (EA) with radical nephroureterectomy (RNU). From 2004 to 2018, cTa/T1N0M0 UTUC patients undergoing EA and RNU were enrolled. For reducing observational bias, propensity scores based on inverse probability of treatment weighting (IPTW) were utilized for comparing the oncologic outcomes and renal function changes. In total, 65 of 184 cTa/T1 UTUC patients were analyzed after exclusion of 119 patients with end-stage renal disease, and lack of previous ureteroscopic biopsy. The studied patients included 23 who received EA and 42 RNU, and both groups were well balanced after adjusting with IPTW. The median follow-up period was 43.6 months. There was no statistical difference between the two groups in terms of oncological outcome. The EA group exhibited less estimated glomerular filtration rate (eGFR) decline one year later (0.0% vs. 20.2%, p < 0.001) and less worsening of chronic kidney status (13.2% vs. 46.5%, p = 0.026). Among patients receiving EA, high-grade tumors exhibited higher subsequent recurrence in the residual urinary tract than did the low-grade ones. (p = 0.037). In summary, endoscopic ablation preserves renal function without compromising oncological outcome in selected UTUC patients. High-grade tumors should be strictly followed up following endoscopic ablation. |
format | Online Article Text |
id | pubmed-8910842 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89108422022-03-11 Outcome of Non-Muscle Invasive Upper Tract Urothelial Carcinoma Receiving Endoscopic Ablation: An Inverse Probability of Treatment Weighting Analysis Shen, Chih-Yu Jou, Yeong-Chin Kan, Wei-Chih Tzai, Tzong-Shin Tsai, Yuh-Shyan J Clin Med Article We compared the outcomes in early-stage upper tract urothelial carcinoma (UTUC) patients receiving endoscopic ablation (EA) with radical nephroureterectomy (RNU). From 2004 to 2018, cTa/T1N0M0 UTUC patients undergoing EA and RNU were enrolled. For reducing observational bias, propensity scores based on inverse probability of treatment weighting (IPTW) were utilized for comparing the oncologic outcomes and renal function changes. In total, 65 of 184 cTa/T1 UTUC patients were analyzed after exclusion of 119 patients with end-stage renal disease, and lack of previous ureteroscopic biopsy. The studied patients included 23 who received EA and 42 RNU, and both groups were well balanced after adjusting with IPTW. The median follow-up period was 43.6 months. There was no statistical difference between the two groups in terms of oncological outcome. The EA group exhibited less estimated glomerular filtration rate (eGFR) decline one year later (0.0% vs. 20.2%, p < 0.001) and less worsening of chronic kidney status (13.2% vs. 46.5%, p = 0.026). Among patients receiving EA, high-grade tumors exhibited higher subsequent recurrence in the residual urinary tract than did the low-grade ones. (p = 0.037). In summary, endoscopic ablation preserves renal function without compromising oncological outcome in selected UTUC patients. High-grade tumors should be strictly followed up following endoscopic ablation. MDPI 2022-02-27 /pmc/articles/PMC8910842/ /pubmed/35268398 http://dx.doi.org/10.3390/jcm11051307 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Shen, Chih-Yu Jou, Yeong-Chin Kan, Wei-Chih Tzai, Tzong-Shin Tsai, Yuh-Shyan Outcome of Non-Muscle Invasive Upper Tract Urothelial Carcinoma Receiving Endoscopic Ablation: An Inverse Probability of Treatment Weighting Analysis |
title | Outcome of Non-Muscle Invasive Upper Tract Urothelial Carcinoma Receiving Endoscopic Ablation: An Inverse Probability of Treatment Weighting Analysis |
title_full | Outcome of Non-Muscle Invasive Upper Tract Urothelial Carcinoma Receiving Endoscopic Ablation: An Inverse Probability of Treatment Weighting Analysis |
title_fullStr | Outcome of Non-Muscle Invasive Upper Tract Urothelial Carcinoma Receiving Endoscopic Ablation: An Inverse Probability of Treatment Weighting Analysis |
title_full_unstemmed | Outcome of Non-Muscle Invasive Upper Tract Urothelial Carcinoma Receiving Endoscopic Ablation: An Inverse Probability of Treatment Weighting Analysis |
title_short | Outcome of Non-Muscle Invasive Upper Tract Urothelial Carcinoma Receiving Endoscopic Ablation: An Inverse Probability of Treatment Weighting Analysis |
title_sort | outcome of non-muscle invasive upper tract urothelial carcinoma receiving endoscopic ablation: an inverse probability of treatment weighting analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910842/ https://www.ncbi.nlm.nih.gov/pubmed/35268398 http://dx.doi.org/10.3390/jcm11051307 |
work_keys_str_mv | AT shenchihyu outcomeofnonmuscleinvasiveuppertracturothelialcarcinomareceivingendoscopicablationaninverseprobabilityoftreatmentweightinganalysis AT jouyeongchin outcomeofnonmuscleinvasiveuppertracturothelialcarcinomareceivingendoscopicablationaninverseprobabilityoftreatmentweightinganalysis AT kanweichih outcomeofnonmuscleinvasiveuppertracturothelialcarcinomareceivingendoscopicablationaninverseprobabilityoftreatmentweightinganalysis AT tzaitzongshin outcomeofnonmuscleinvasiveuppertracturothelialcarcinomareceivingendoscopicablationaninverseprobabilityoftreatmentweightinganalysis AT tsaiyuhshyan outcomeofnonmuscleinvasiveuppertracturothelialcarcinomareceivingendoscopicablationaninverseprobabilityoftreatmentweightinganalysis |